Day: November 13, 2025

Atlanta, Nov. 13, 2025 (GLOBE NEWSWIRE) — Piedmont Realty Trust, Inc. (the “Company” or “Piedmont”) (NYSE:PDM) announced today that its operating partnership, Piedmont Operating Partnership, LP (the “Operating Partnership”), has priced an offering of $400 million aggregate principal amount of 5.625% senior notes due 2033 at 99.364% of the principal amount. The offering is expected to close on November 20, 2025, subject to the satisfaction of customary closing conditions. Piedmont intends to use the net proceeds from the offering, together with borrowings under its $600 million unsecured line of credit and cash on hand, if necessary, to fund the purchase of all of its outstanding 9.250% senior notes due 2028 that are validly tendered and accepted for purchase in the tender offer commenced substantially concurrently with the offering....

MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of 4,189,000 shares of its common stock at a price of $1.11 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase 7,523,000 shares of common stock at an offering price of $1.1099 per pre-funded warrant, which represents the per share offering price for the shares of common stock less the $0.0001 per share exercise price. The gross proceeds to TELA from the offering, before deducting underwriting discounts and estimated offering expenses, are expected to be approximately $13.0 million, assuming no exercise of the pre-funded...

BROSSARD, Quebec, Nov. 13, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces that it intends to extend the exercise period of an aggregate of 3,502,931 stock warrants (each a “Warrant”) issued as part of a non-brokered private placement of units initially announced on June 5, 2024 and set to expire on December 5, 2025. Subject to the TSX Venture Exchange (the “Exchange”) consent, the extended expiry date shall be August 5, 2026 (the “Amendment”). All other provisions of the Warrants, such as the Warrants exercise price of $0.40 per common share of the Corporation, will remain unchanged and fully in effect during the extended exercise period. The...